Exploiting cancer's antioxidative weakness through p53 with nanotoxicology

Nanomedicine

Volumn 9, Issue 4, 2014, Pages 369-371

  Setyawati, Magdiel Inggrid ^a   Tay, Chor Yong ^a   Leong, David Tai ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

anticancer; nanomedicine; nanotoxicity; oxidative stress; p53

Indexed keywords

ANTIOXIDANT; NANOPARTICLE; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

CANCER THERAPY; CELL FUNCTION; HUMAN; NANOTECHNOLOGY; NANOTOXICOLOGY; NEOPLASM; PRIORITY JOURNAL; REVIEW; ANIMAL; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; NANOMEDICINE; NEOPLASMS; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; MOLECULAR TARGETED THERAPY; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84899784542     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.6     Document Type: Review

References (20)

1. Tan GR, Feng SS, Leong DT. The reduction of anti-cancer drug antagonism by the spatial protection of drugs with PLA-TPGS nano particles. Biomaterials 35(9), 3044-3051 (2014
2. Schutz CA, Juillerat-Jeanneret L, Mueller H, Lynch I, Riediker M. Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine (Lond.) 8(3), 449-467 (2013
3. Setyawati MI, Tay CY, Chia SL et al. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat. Commun.4, 1673 (2013
4. Tay CY, Cai PQ, Setyawati MI et al. Nanoparticles strengthen intracellular tension and retard cellular migration. Nano Lett.14(1), 83-88 (2014
5. Setyawati MI, Fang W, Chia SL, Leong DT. Nanotoxicology of common metal oxide based nanomaterials: Their ROS-y and non-ROS-y consequences. Asia-Pac.J. Chem. Eng.8(2), 205-217 (2013
6. Van Oijen MGCT, Slootweg PJ. Gain-of-function mutations in the tumor suppressor gene p53. Clin. Cancer Res.6(6), 2138-2145 (2000
7. Liu B, Chen Y, St Clair DK. ROS and p53: A versatile partnership. Free Radic. Biol. Med.44(8), 1529-1535 (2008
8. Lane D, Levine A.p53 research: The past thirty years and the next thirty years. Cold Spring Harbor Perspect. Biol.2(12), a000893 (2010
9. Satapathy SR, Mohapatra P, Preet R et al. Silver-based nanoparticles induce apoptosis in human colon cancer cells mediated through p53. Nanomedicine (Lond.) 8(8), 1307-1322 (2013
10. Setyawati MI, Khoo PKS, Eng BH et al. Cytotoxic and genotoxic characterization of titanium dioxide, gadolinium oxide, and poly(lactic-co- glycolic acid) nanoparticles in human fibroblasts.J. Biomed. Mater. Res. Part A 101A(3), 633-640 (2013
11. Asharani PV, Xinyi N, Hande MP, Valiyaveettil S. DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles. Nanomedicine (Lond.) 5(1), 51-64 (2010
12. Apel K, Hirt H. Reactive oxygen species: Metabolism, oxidative stress, and signal transduction. Annu. Rev. Plant Biol.55, 373-399 (2004
13. Ng KW, Khoo SPK, Heng BC et al. The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles. Biomaterials 32(32), 8218-8225 (2011
14. Ahamed M, Akhtar MJ, Raja M et al. ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: Role of oxidative stress. Nanomedicine 7(6), 904-913 (2011
15. Setyawati MI, Tay CY, Leong DT. Effect of zinc oxide nanomaterials- induced oxidative stress on the p53 pathway. Biomaterials 34(38), 10133-10142 (2013
16. Wu J, Sun J, Xue Y. Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells. Toxicol. Lett.199(3), 269-276 (2010
17. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nat. Med.11(12), 1306-1313 (2005
18. Hashizume H, Baluk P, Morikawa S et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am.J. Pathol.156(4), 1363-1380 (2000
19. Zhu Y, Eaton JW, Li C. Titanium dioxide (TiO2) nanoparticles preferentially induce cell death in transformed cells in a Bak/ Bax-independent fashion. PLoS ONE 7(11), e50607 (2012
20. Ahamed M, Alhadlaq H, Khan MaM, Akhtar MJ. Selective killing of cancer cells by iron oxide nanoparticles mediated through reactive oxygen species via p53 pathway.J. Nanopart. Res.15(1), 1-11 (2012.